Market Place
Sourcing Support
Marinomed Biotech AG announces results for the first quarter of 2024
22 May 2024 //
PHARMIWEB
Marinomed and Friedrich-Alexander-Universität Erlangen-Nürnberg publish new data
09 Dec 2021 //
MARINOMED
Luoxin, Marinomed Biotech Sign Agreement for Budesolv Budesonide Nasal Spray
21 Oct 2021 //
BIOSPACE
Marinomed Biotech AG and Luoxin Pharma sign agreement on Budesolv
20 Oct 2021 //
DGAP
Marinomed Biotech signs financing agreement with Nice & Green
05 Oct 2021 //
YAHOO
Marinomed Biotech AG Reports Financial Results for 1st Half 2021
25 Aug 2021 //
BLOOMBERG
Marinomed Biotech AG Grants Exclusive Rights for Carragelose
07 Jul 2021 //
PR NEWSWIRE
Marinomed Biotech AG Grants Exclusive Rights for Carragelose
07 Jul 2021 //
PR NEWSWIRE
Marinomed Reports Encouraging Data for Phase II Clinical Trial of Tacrosolv
01 Jul 2021 //
DGAP
Marinomed Biotech announces positive data demonstrating efficacy SARS-CoV-2
21 Apr 2021 //
PHARMABIZ
Marinomed Biotech Reports Financial Results for Fiscal Year 2020
14 Apr 2021 //
MARINOMED
Marinomed Biotech enrolls first patient in clinical study of inhaled Carragelose
25 Mar 2021 //
MARINOMED
Marinomed Biotech : Enrolls First Patients in PH II Trial of Tacrosolv
11 Mar 2021 //
MARKETSCREENER
Marinomed Biotech announces clinical trial at Swansea University
01 Dec 2020 //
PHARMABIZ
Marinomed expands into Italy and broadens its portfolio
03 Jun 2020 //
MARINOMED
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.